Neurodegenerative diseases like Alzheimer’s, Parkinson’s, Huntington’s, ALS, and Multiple Sclerosis are some of the most complex and challenging conditions in medical research. These disorders, driven by progressive neuronal degeneration, cause debilitating symptoms that vary widely among patients. Download our white paper to discover the critical role protein biomarkers play in early diagnosis, tracking disease progression, and evaluating treatment efficacy in clinical trials.
Authors:
Jayaprakash (JP) Kotha, MBBS, PhD, ASCP (SH)
Vice President, Bioanalytical Laboratory
Tom Zhang, PhD
Chief Scientific Officer, Large Molecule Bioanalysis
Mike Mencer
Executive Vice President and General Manager, Early Phase
Henry J. Riordan, PhD
Chief Development Officer
Tom Babic, MD, PhD
Vice President, Scientific Solutions, Neuroscience
Sherilyn Adcock, RPh, PhD
Chief Scientific Officer, Early Phase Development
Lona Sheeran
Senior Vice President, Clinical Operations Early Phase
